Efficacy and Safety of Intranasal Glucagon for Treatment of Induced Hypoglycemia in Adults with Diabetes

Trial Profile

Efficacy and Safety of Intranasal Glucagon for Treatment of Induced Hypoglycemia in Adults with Diabetes

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Oct 2016

At a glance

  • Drugs Glucagon (Primary) ; Glucagon
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Registrational; Therapeutic Use
  • Sponsors AMG Medical
  • Most Recent Events

    • 17 Dec 2015 Results published in the Diabetes Care
    • 14 Apr 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 07 Jan 2015 Planned End Date changed from 1 Oct 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top